NASDAQ:RMTI • US7743743004
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ROCKWELL MEDICAL INC (RMTI).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-11-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-25 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-14 | Rodman & Renshaw | Initiate | Buy |
| 2024-09-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-25 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-05 | Maxim Group | Initiate | Buy |
| 2023-10-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-17 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-30 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-02 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-04 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-13 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-08 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-30 | HC Wainwright & Co. | Maintains | Buy |
| 2022-01-18 | HC Wainwright & Co. | Maintains | Buy |
| 2021-09-07 | HC Wainwright & Co. | Maintains | Buy |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 72.81M 17.57% | 83.612M 14.84% | 101.489M 21.38% | 70.883M -30.16% | 76.656M 8.14% | 79.475M 3.68% | N/A | |
| EBITDA YoY % growth | -16.2M 45.40% | -5.226M 67.74% | 2.788M 153.35% | 1.033M -62.95% | 2.832M 174.15% | 3.983M 40.64% | N/A | |
| EBIT YoY % growth | -16.78M 44.69% | -6.67M 60.25% | 608K 109.12% | -3.372M -654.54% | -1.189M 64.73% | -459K 61.41% | 12.75M 2,877.78% | |
| Operating Margin | -23.05% | -7.98% | 0.60% | -4.76% | -1.55% | -0.58% | N/A | |
| EPS YoY % growth | -2.00 29.58% | -0.40 80.00% | -0.02 94.75% | -0.16 -652.86% | -0.06 64.52% | -0.04 27.27% | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.02 202.00% | -0.02 49.00% | -0.03 38.80% | -0.02 59.20% | -0.02 -200.00% |
| Revenue Q2Q % growth | 18.953M -23.16% | 18.315M -3.17% | 18.227M 13.42% | 18.674M 17.25% | 19.343M 2.06% |
| EBITDA Q2Q % growth | 1.618M -2.59% | 128.52K 115.65% | 11.22K 104.54% | 98.94K -82.40% | 176.46K -89.09% |
| EBIT Q2Q % growth | 1.007M 294.03% | -1.109M 18.48% | -1.185M 12.14% | -1.094M -0.96% | -1.099M -209.09% |
All data in USD
8 analysts have analysed RMTI and the average price target is 3.83 USD. This implies a price increase of 325.28% is expected in the next year compared to the current price of 0.8994.
ROCKWELL MEDICAL INC (RMTI) will report earnings on 2026-03-26, after the market close.
The consensus EPS estimate for the next earnings of ROCKWELL MEDICAL INC (RMTI) is 0.02 USD and the consensus revenue estimate is 18.95M USD.
The expected long term growth rate for ROCKWELL MEDICAL INC (RMTI) is -8.13%.